Page not found
It has either moved or doesn't exists any more.
Please browse the links below:
Latest News
-
Notice of results
16 September 2025 -
Holding(s) in Company
11 September 2025 -
Submission of new Phase III study protocol to FDA for expanded indication of XENOVIEW
12 August 2025
View About us
About Us
Latest Annual Report
Investor Alert
Sign up for Email Alerts